On February 3, 2025, Zest Health announced it secured $13 million in seed funding, with Roivant Health incubating and making an investment in the company. Zest Health is a value-based virtual care company focused on treating patients with inflammatory skin diseases. This investment highlights Roivant's strategic interest in health technology solutions.
Zest Health's platform aims to provide personalized dermatology care, reducing unnecessary pharmaceutical utilization while achieving sustainable clinical outcomes. The company targets the approximately 40 million Americans suffering from eczema and psoriasis, conditions often associated with long wait times and reliance on systemic medications.
Roivant Health's involvement leverages its expertise in inflammatory disease innovation and transformative health technologies. The funds will be used to scale Zest's existing partnerships with health plans and employers. This initiative seeks to address the growing cost pool associated with chronic skin conditions by offering higher quality care that simultaneously reduces expenses.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.